ALNYLAM PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$165.00
-5.17%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-28.6%
3 months
-25.1%
6 months
-44.3%
1 year
-63.3%
Year to date
-58.5%
52-week range
$165.00 – $473.29
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$22.1B
P/E
8.1
P/B
6.1
P/S
4.4
Revenue
$5.01B
Net income
$2.72B
Diluted EPS
19.82
Gross margin
77.30%
Net margin
54.30%
Return on equity
159.70%
Total debt
$3B
Cash
$1.75B
Free cash flow
$752.13M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $1.46B | $2.17B | 75.20% | 148.60% | $271.15M |
| Jun 30, 2026 | $1.29B | $164.49M | 76.90% | 12.70% | $292.04M |
| Mar 31, 2026 | $1.17B | $205.99M | 81.90% | 17.60% | $48.67M |
| Dec 31, 2025 | $1.1B | $186.42M | 75.60% | 17.00% | $140.26M |
| Sep 30, 2025 | $1.25B | $251.08M | 84.00% | 20.10% | $312.97M |
| Jun 30, 2025 | $773.69M | -$66.28M | 81.50% | -8.60% | $139.44M |
| Mar 31, 2025 | $594.19M | -$57.48M | 88.00% | -9.70% | -$127.28M |
| Dec 31, 2024 | $593.17M | -$83.76M | 82.70% | -14.10% | -$103.76M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ALNY news
All market newsNo ticker-linked stories are in the current archive.